INDEGENE
Back to All Ratios
|
INDEGENE Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/EBIT(x) | 0.50 | 0.89 | -2.15 | -0.48 | 3.22 |
What is the latest EV/EBIT ratio of INDEGENE ?
Year | EV/EBIT |
---|---|
Mar2024 | 0.50 |
Mar2023 | 0.89 |
Mar2022 | -2.15 |
Mar2021 | -0.48 |
Mar2020 | 3.22 |
How is EV/EBIT of INDEGENE Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 0.5 | -43.82 | |
Mar2023 | 0.89 | Positive | |
Mar2022 | -2.15 | Negative | |
Mar2021 | -0.48 | Negative | |
Mar2020 | 3.22 | - |
Other Financial Ratios of INDEGENE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses